- Weekly* report on COVID-19 vaccination coverage in England, based on the population of 23.4m people registered with practices that use TPP SystmOne software. * please note, updates will occur most weeks but not all.
- Get in touch and tell us how you use this report or new features you'd like to see: [email protected]
- First published
- 22 Dec 2020
- Last updated
- 15 Sep 2021
OpenSAFELY COVID Vaccine coverage report¶
OpenSAFELY is a new secure analytics platform for electronic patient records built on behalf of NHS England to deliver urgent academic and operational research during the pandemic.
This is our regular weekly report on COVID-19 vaccination coverage in England using data from 40% of general practices that use TPP electronic health record software. The data requires careful interpretation and there are a number of caveats. Please read the full detail about our methods and discussion of our earlier results (as of January 13th) in our preprint paper available here.
The full analytical methods behind the latest results in this report are available here.
- Summary Charts
- Trends in vaccination coverage according to demographic/clinical features, for:
- Current vaccination coverage of each eligible population group, according to demographic/clinical features
- Appendix: Proportion of each population group for whom ethnicity is known
|first dose as at 08 Sep 2021||second dose as at 08 Sep 2021|
|Total vaccinated in TPP||16,104,788||14,683,081|
|80+||96.3% (1,045,499 of 1,085,189)||95.1% (1,031,905 of 1,085,189)|
|70-79||95.9% (1,977,493 of 2,061,052)||94.9% (1,955,793 of 2,061,052)|
|care home||95.7% (83,076 of 86,807)||92.3% (80,143 of 86,807)|
|shielding (aged 16-69)||90.6% (760,389 of 838,964)||87.1% (730,597 of 838,964)|
|65-69||93.5% (1,002,904 of 1,072,792)||92.2% (989,394 of 1,072,792)|
|LD (aged 16-64)||87.0% (72,345 of 83,202)||81.5% (67,788 of 83,202)|
|60-64||91.7% (1,174,173 of 1,279,768)||90.1% (1,153,068 of 1,279,768)|
|55-59||89.9% (1,363,040 of 1,515,948)||87.8% (1,331,484 of 1,515,948)|
|50-54||87.6% (1,374,527 of 1,568,777)||85.0% (1,332,849 of 1,568,777)|
|40-49||80.0% (2,372,370 of 2,965,452)||75.4% (2,234,638 of 2,965,452)|
|30-39||69.2% (2,310,623 of 3,339,980)||60.3% (2,014,845 of 3,339,980)|
|18-29||65.9% (2,300,599 of 3,491,607)||48.8% (1,702,750 of 3,491,607)|
|16-17||50.9% (267,757 of 525,938)||11.0% (57,827 of 525,938)|
- The care home group is defined based on patients (aged 65+) having one of these codes.
The LD (learning disability) group is defined based on this codelist and excludes people who are shielding.
Patients are counted in their highest risk category only; e.g. a 65-year-old who is shielding is only counted in the shielding group, not in the 65-69 population
Oxford-AZ vaccines (% of all first doses): 52.2% (8,411,606)
Pfizer vaccines (% of all first doses): 45.3% (7,298,242)
Moderna vaccines (% of all first doses): 2.5% (399,273)
Second doses and dose combinations¶
Note: second dose figures are raw proportions and do not take into account how many are due, which is likely to vary substantially by brand.
For more detailed analysis please refer to our second dose report
Second doses (% of all vaccinated): 91.2% (14,683,081)
Second doses (% of Ox-AZ first doses): 97.3% (8,188,348)
Second doses (% of Pfizer first doses): 85.1% (6,208,258)
Second doses (% of Moderna first doses): 73.1% (291,746)
Note: mixed doses counts patients with two doses at least 19 days apart, excluding patients with two different brands recorded on the same day or where the first dose was recorded on a date prior to when the given brand was available in the UK
Mixed doses Ox-AZ + Pfizer (% of fully vaccinated): 0.3% (39851)
Mixed doses Ox-AZ + Moderna (% of fully vaccinated): 0.0% (1925)
Mixed doses Moderna + Pfizer (% of fully vaccinated): 0.0% (2702)
Note: 'Priority groups' only includes those identified as being in a priority group by our methodology. 'Others' includes everyone aged 18-49 except those who are shielding or have a learning disability.